Synthesis and biodistribution of 2-[123I]iodomelatonin in normal mice

Applied Radiation and Isotopes

Volumn 64, Issue 1, 2006, Pages 38-42

  Al Jammaz, I ^a   Al Otaibi, B ^a   Aboul Enein, H ^a   Amartey, J K ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Iodine 123; Iodomelatonin; Melatonin; Radioiodination

Indexed keywords

ACETIC ACID; CELLS; IODINE COMPOUNDS; OXIDATION; RADIOACTIVE TRACERS; SYNTHESIS (CHEMICAL); THERMAL EFFECTS;

IODINE-123; IODOMELATONIN; MELATONIN; RADIOIODINATION;

HORMONES;

2 IODOMELATONIN; 2 IODOMELATONIN I 123; IODINE 123; OXIDIZING AGENT; PERACETIC ACID; RADIOPHARMACEUTICAL AGENT; SODIUM IODIDE I 131; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG SYNTHESIS; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIODINATION; REACTION TIME; ROOM TEMPERATURE; TISSUE DISTRIBUTION;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; IODINE RADIOISOTOPES; ISOTOPE LABELING; MELATONIN; MICE; MICE, INBRED CBA; TISSUE DISTRIBUTION;

EID: 27644545049     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2005.06.012     Document Type: Article

References (11)

1. 11C]melatonin: potential PET tracer for melatonin binding sites Appl. Radiat. Isot. 49 12 1998 1573 1579
2. 2 J. Label. Compd. Radiopharm. 23 1986 1011 1020
3. 125I]iodomelatonin binding sites in djungarian Endocrinology 125 2 1989 1011 1018
4. J. Hughes Electromagnetic fields and brain tumours: a commentary Teratog. Carcinog. Mutagen. 14 5 1994 213 217
5. R. Lambrecht, M. Sajjad, R. Syed, and W. Meyer Target preparation and recovery of enriched isotopes for medical radionuclide production Nucl. Instrum. Methods A 282 1989 296 302
6. P. Lissoni, S. Barni, M. Cazzaniga, A. Ardizzoia, F. Rovelli, F. Brivio, and G. Tancini Efficacy of the concomitant administration of the pineal hormone melatonin in cancer immunotherapy with low dose IL-2 in patients with advanced solid tumours who had progressed on IL-2 alone Oncology 51 4 1994 344 347
7. P. Lissoni, P. Barni, S. Tancini, G. Mainini, E. Piglia, F. Maestroni, and J. Lewinski Immunoendocrine therapy with low-dose subcutaneous interleukin-2 plus melatonin of locally advanced or metastatic endocrine tumours Oncology 52 2 1995 163 166
8. 123I]iodomelatonin Appl. Radiat. Isot. 45 1994 902 905
9. B. Stankov, M. Gervasoni, F. Scaglione, R. Perego, D. Cova, L. Marabini, and F. Fraschini Primary pharmaco-toxicological evaluation of 2-iodomelatonin, a potent melatonin agonist Life Sci. 53 17 1993 1357 1365
10. O. Vakkuri, J. Leppaluoto, and O. Vuolteenaho Development and validation of a melatonin radioimmunoassay using radioiodinated melatonin as a tracer Acta Endocrine 106 1984 152 157
11. M. Webb, and P.-D. Manuel Role of melatonin in health and disease Clinl. Endocrinol. 42 1995 221 234